Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAURITE 2: Single and Repeat Dose IPN10200 for Moderate to Severe Glabellar Lines
jRCT2031250845Phase 3Recruiting
- Sponsor
- Ipsen
- Start
- Mar 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial of corabotase in glabellar furrowing (3 arms), sponsored by Ipsen. Started Mar 2026; status: recruiting.
02
Drugs
corabotase
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on jRCT2031250845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250845.